Cetera Investment Advisers Biogen Inc. Transaction History

Cetera Investment Advisers

$45.9 Billion
Q4 2024

A detailed history of Cetera Investment Advisers transactions in Biogen Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 13,269 shares of BIIB stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,269

Previous 12,869 3.11%

Holding current value

$1.84 Million

Previous $2.49 Million 18.64%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$146.47 - $191.55 $58,588 - $76,620	400 Added 3.11%	13,269 $2.03 Million
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $208,922 - $261,664	-1,105 Reduced 7.91%	12,869 $2.49 Million
Q2 2024 Aug 22, 2024	SELL	$190.52 - $236.72 $168,800 - $209,733	-886 Reduced 5.96%	13,974 $3.24 Million
Q1 2024 May 24, 2024	BUY	$212.02 - $267.71 $2.37 Million - $2.99 Million	11,184 Added 304.24%	14,860 $3.2 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $160,923 - $203,191	-759 Reduced 17.11%	3,676 $792,000
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $890 - $1,071	4 Added 0.09%	4,435 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $74,976 - $84,623	296 Added 7.16%	4,431 $1.14 Million
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $16,790 - $19,401	-61 Reduced 1.45%	4,135 $1.18 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $31,556 - $35,957	123 Added 3.02%	4,196 $1.17 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $542,241 - $658,834	2,148 Added 111.58%	4,073 $1.13 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $289,504 - $399,200	-1,487 Reduced 43.58%	1,925 $514,000
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $2,062 - $2,453	-11 Reduced 0.32%	3,412 $696,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $75,764 - $95,458	-391 Reduced 10.25%	3,423 $721,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $27,542 - $35,395	-123 Reduced 3.12%	3,814 $915,000
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $122,817 - $160,167	-434 Reduced 9.93%	3,937 $1.11 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $58,793 - $94,139	227 Added 5.48%	4,371 $1.51 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $149,414 - $175,047	-615 Reduced 12.92%	4,144 $1.16 Million
Q4 2020 Feb 17, 2021	BUY	$236.26 - $355.63 $951,182 - $1.43 Million	4,026 Added 549.25%	4,759 $1.17 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $194,076 - $224,085	733 New	733 $208,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $206,152 - $273,012	-797 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$268.85 - $341.04 $214,273 - $271,808	797 New	797 $252,000
Q1 2019 May 06, 2019	SELL	$216.71 - $338.96 $153,213 - $239,644	-707 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$278.5 - $352.75 $557 - $705	-2 Reduced 0.28%	707 $212,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $93,042 - $121,674	-317 Reduced 30.9%	709 $250,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,026	1,026 $281,000

Others Institutions Holding BIIB

# of Institutions

996

Shares Held

129M

Call Options Held

1.37M

Put Options Held

1.51M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Biogen Inc. Transaction History